Erowid
 
 
Plants - Drugs Mind - Spirit Freedom - Law Arts - Culture Library  
References Database

References Search
All References with Titles containing 'Johnson_M' OR with Authors including 'Johnson_M' OR with Abstract including 'Johnson_M' OR with Keywords including 'Johnson_M'


Author Title JournalName Year   D
Click on Column Headers to Re-Sort The Current List
Johnson MP, Hoffman AJ, N... Effects of the enantiomers of MDA, MDMA and related analogues on [3H]s... Eur J Pharmacol 1986
Stone DM, Johnson M, Hans... A comparison of the neurotoxic potential of methylenedioxyamphetamine ... Eur J Pharmacol 1987
Johnson M, Hanson GR, Gib... Effects of dopaminergic and serotonergic receptor blockade on neuroche... Neuropharmacology 1988
Johnson M, Letter AA, Mer... Effects of 3,4-methylenedioxyamphetamine and 3,4-methylenedioxymethamp... J Pharmacol Exp Ther 1988
Stone DM, Johnson M, Hans... Role of endogenous dopamine in the central serotonergic deficits induc... J Pharmacol Exp Ther 1988
Johnson M, Hanson GR, Gib... Effect of MK-801 on the decrease in tryptophan hydroxylase induced by ... Eur J Pharmacol 1989
Johnson M, Stone DM, Bush... Glucocorticoids and 3,4-methylenedioxymethamphetamine (MDMA)-induced n... Eur J Pharmacol 1989
Johnson MP, Nichols DE Neurotoxic effects of the alpha-ethyl homologue of MDMA following suba... Pharmacol Biochem Be... 1989
Nichols DE, Oberlender R,... Studies of dioxole ring substituted 3,4-methylenedioxyamphetamine (MDA... Pharmacol Biochem Be... 1989
Stone DM, Johnson M, Hans... Acute inactivation of tryptophan hydroxylase by amphetamine analogs in... Eur J Pharmacol 1989
Gibb JW, Stone DM, Johnso... Role of dopamine in the neurotoxicity induced by amphetamines and rela... NIDA Res Monogr 1989
Hanson GR, Sonsalla P, Le... Effects of amphetamine analogs on central nervous system neuropeptide ... NIDA Res Monogr 1989
Herkenham M, Lynn AB, Lit... Cannabinoid receptor localization in brain Proc Natl Acad Sci U... 1990
Gibb JW, Johnson M, Hanso... Neurochemical basis of neurotoxicity Neurotoxicology 1990
Gibb JW, Johnson M, Stone... MDMA: historical perspectives Ann N Y Acad Sci 1990
Johnson MP, Huang XM, Obe... Behavioral, biochemical and neurotoxicological actions of the alpha-et... Eur J Pharmacol 1990
Nichols DE, Brewster WK, ... Nonneurotoxic tetralin and indan analogues of 3,4-(methylenedioxy)amph... J Med Chem 1990
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Callaway CW, Johnson MP, ... Amphetamine derivatives induce locomotor hyperactivity by acting as in... Psychopharmacology (... 1991
Huang XM, Johnson MP, Nic... Reduction in brain serotonin markers by alpha-ethyltryptamine (Monase) Eur J Pharmacol 1991
Johnson M, Bush LG, Gibb ... Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in n... Eur J Pharmacol 1991
Johnson MP, Conarty PF, N... [3H]monoamine releasing and uptake inhibition properties of 3,4-methyl... Eur J Pharmacol 1991
Johnson MP, Frescas SP, O... Synthesis and pharmacological examination of 1-(3-methoxy-4-methylphen... J Med Chem 1991
Johnson MP, Huang XM, Nic... Serotonin neurotoxicity in rats after combined treatment with a dopami... Pharmacol Biochem Be... 1991
Nichols DE, Johnson MP, O... 5-Iodo-2-aminoindan, a nonneurotoxic analogue of p-iodoamphetamine Pharmacol Biochem Be... 1991
Steele TD, Brewster WK, J... Assessment of the role of alpha-methylepinine in the neurotoxicity of ... Pharmacol Biochem Be... 1991
Hanson GR, Bunker CF, Joh... Response of monoaminergic and neuropeptide systems to 4-methylaminorex... Eur J Pharmacol 1992
Elayan I, Gibb JW, Hanson... Long-term alteration in the central monoaminergic systems of the rat b... Eur J Pharmacol 1992
Johnson M, Elayan I, Hans... Effects of 3,4-dihydroxymethamphetamine and 2,4,5-trihydroxymethamphet... J Pharmacol Exp Ther 1992
Johnson M, Mitros K, Ston... Effect of flunarizine and nimodipine on the decrease in tryptophan hyd... J Pharmacol Exp Ther 1992
Elayan I, Gibb JW, Hanson... Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymet... J Pharmacol Exp Ther 1993
Johnson M, Bush LG, Hanso... Effects of ritanserin on the 3,4-methylenedioxymethamphetamine-induced... Biochem Pharmacol 1993
Cohen ML, Johnson MP, Sch... DOI and alpha-methylserotonin: comparative vascular and nonvascular sm... J Pharmacol Exp Ther 1993
Che S, Johnson M, Hanson ... Body temperature effect on methylenedioxymethamphetamine-induced acute... Eur J Pharmacol 1995
Sprague JE, Johnson MP, S... Studies on the mechanism of p-chloroamphetamine neurotoxicity Biochem Pharmacol 1996
Gibb JW, Johnson M, Elaya... Neurotoxicity of amphetamines and their metabolites NIDA Res Monogr 1997
Hanson GR, Jensen M, John... Distinct features of seizures induced by cocaine and amphetamine analo... Eur J Pharmacol 1999
Griffiths RR, Richards WA... Mystical-type experiences occasioned by psilocybin mediate the attribu... J Psychopharm 2008
Johnson MW, Richards WA, ... Human hallucinogen research: guidelines for safety J Psychopharmacol. 2008
Johnson MW, Maclean KA, R... Human psychopharmacology and dose-effects of salvinorin A, a kappa opi... Drug Alcohol Depend 2010
MacLean KA, Johnson MW, G... Mystical experiences occasioned by the hallucinogen psilocybin lead to... J Psychopharmacol 2011
Griffiths RR, Johnson MW,... Psilocybin occasioned mystical-type experiences: immediate and persist... Psychopharmacology (... 2011
Reissig CJ, Carter LP, Jo... High doses of dextromethorphan, an NMDA antagonist, produce effects si... Psychopharmacology (... 2012
Johnson MW, Garcia-Romeu ... Pilot study of the 5-HT2AR agonist psilocybin in the treatment of toba... J Psychopharmacol 2014
Johnson MW, MacLean KA, C... Time course of pharmacokinetic and hormonal effects of inhaled high-do... J Psychopharmacol 2016
Liao Y, Tang J, Liu J, Xi... Decreased Thalamocortical Connectivity in Chronic Ketamine Users PLoS One 2016
Paul MJ, Chisolm MS, John... Assessing the Validity of Online Drug Forums as a Source for Estimatin... J Addict Med 2016
Carbonaro TM, Bradstreet ... Survey study of challenging experiences after ingesting psilocybin mus... J Psychopharmacol 2016
Johnson MW, Garcia-Romeu ... An online survey of tobacco smoking cessation associated with naturali... J Psychopharmacol 2017
Nichols DE, Johnson MW, N... Psychedelics as Medicines: An Emerging New Paradigm Clin Pharmacol Ther 2017
Saleemi S, Pennybaker SJ,... Who is 'Molly'? MDMA adulterants by product name and the impact of har... J Psychopharmacol 2017
Barrett FS, Johnson MW, G... Neuroticism is associated with challenging experiences with psilocybin... Personality and Indi... 2017
Carbonaro TM, Johnson MW,... Double-blind comparison of the two hallucinogens psilocybin and dextro... Psychopharmacology (... 2017
Davis AK, Clifton JM, Wea... Survey of entity encounter experiences occasioned by inhaled N,N-dimet... J Psychopharmacol 2020